Zimmer Biomet Balance Sheet
ZBH / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
Zimmer Biomet had $23.1B in total assets and $12.7B in shareholders' equity as of FY2025. Total debt was $6.9B against $592M in cash, resulting in $6.3B net debt.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $591.9M | $525.5M | $415.8M | $375.7M | $378.1M | $802.1M | $617.9M | $542.8M | $524.4M | $1.1B | $1.5B | $1.1B | $1.1B | $668.9M | $691.7M |
| Accounts Receivable | $1.7B | $1.5B | $1.4B | $1.4B | $1.3B | $1.5B | $1.4B | $1.3B | $1.5B | $1.6B | $1.4B | $912.1M | $936.6M | $884.6M | $838.8M |
| Inventory | $2.3B | $2.2B | $2.4B | $2.1B | $2.1B | $2.5B | $2.4B | $2.3B | $2.1B | $2.0B | $2.3B | $1.2B | $1.1B | $995.3M | $929.8M |
| Current Assets | $5.1B | $4.7B | $4.6B | $4.4B | $4.9B | $5.1B | $4.7B | $4.4B | $4.6B | $4.7B | $5.9B | $4.3B | $4.2B | $3.7B | $3.3B |
| PP&E (Net) | $2.2B | $2.0B | $2.1B | $1.9B | $1.8B | $2.0B | $2.1B | $2.0B | $2.0B | $2.0B | $2.1B | $1.3B | $1.2B | $1.2B | $1.2B |
| Goodwill | $9.9B | $9.0B | $8.8B | $8.6B | $8.9B | $9.0B | $9.6B | $10.7B | $10.7B | $9.9B | $9.9B | $2.5B | $2.6B | $2.6B | $2.6B |
| Total Assets | $23.1B | $21.4B | $21.5B | $21.1B | $23.5B | $24.4B | $24.6B | $24.1B | $26.0B | $26.7B | $27.2B | $9.7B | $9.6B | $8.5B | $8.0B |
| Current Liabilities | $2.6B | $2.5B | $2.9B | $2.4B | $3.5B | $2.6B | $3.4B | $2.4B | $3.1B | $2.4B | $1.6B | $1.0B | $1.0B | $866.0M | $867.1M |
| Total Debt | $6.9B | $5.3B | $4.9B | $5.2B | $1.0B | $7.6B | $6.7B | $8.4B | $8.9B | $10.7B | $11.5B | $1.4B | $1.7B | $1.7B | $1.6B |
| Shareholders' Equity | $12.7B | $12.5B | $12.5B | $12.0B | $12.7B | $12.2B | $12.4B | $11.3B | $11.7B | $9.7B | $9.9B | $6.5B | $6.3B | $5.9B | $5.5B |